Newsletter

Raynaud's Phenomenon
With symptomatic approaches, Raynaud’s phenomenon market needs a curative option to offer relief to patients.
Raynaud's Phenomenon Newsletter

More Whitepapers / Newsletters

Digital Therapeutics In Mental Health Whitepaper
Digital Therapeutics In Mental...

Digital therapies are evidence-based clinical approaches powered by software applications designed to prevent, control or treat a particular disease or condition. While advances in technology-assisted...

Induced Pluripotent Stem Cells (IPSCs) Research And Development
Induced Pluripotent Stem Cells...

IPSCs have enormous applications in the field of regenerative medicine, disease modelling, and drug discovery. For the development of regenerative medicine, somatic cells from a diseased patient are u...

Healthcare Performance Whitepaper
Healthcare Performance Whitepa...

Healthcare Performance Improvement provides proven methods for sustaining and building a culture of safety. In order to build a new, patient-centric continuum of care, a fundamental restructuring of t...

Pompe Disease Newsletter
Pompe Disease

An autosomal metabolic disorder – Pompe disease results in deterioration of organs and tissues as a consequence of excess accumulation of glycogen in muscle and nerve cells throughout the body. Also c...

Multiple Myeloma Market
Multiple Myeloma

Multiple myeloma (MM) is a cancer of the blood that begins in the bone marrow. In myeloma, plasma cells develop into cancerous myeloma cells. Multiple myeloma is not widespread cancer; however, it has...